L. Lucero

发表

Distinctive nicotinic acetylcholine receptor functional phenotypes of rat ventral tegmental area dopaminergic neurons

Xuechu Zhen, R. Lukas, Qiang Liu, 2009, The Journal of physiology.

nicotinic acetylcholine receptors in rat midbrain dopamine neurons

R. Lukas, Andrew A. George, S. Marxer-Miller, 2004 .

Function Of Human Î±3Î24Î±5 Nicotinic Acetylcholine Receptors Is Reduced By The Î25(D398N) Variant

R. Lukas, Xiangning Chen, M. Damaj, 2021 .

Function of Human α3β4α5 Nicotinic Acetylcholine Receptors Is Reduced by the α5(D398N) Variant*

R. Lukas, Xiangning Chen, M. Damaj, 2012, The Journal of Biological Chemistry.

α-Conotoxins Identify the α3β4* Subtype as the Predominant Nicotinic Acetylcholine Receptor Expressed in Human Adrenal Chromaffin Cells

J. Lindstrom, J. McIntosh, P. Whiteaker, 2015, Molecular Pharmacology.

The Unique α4(+)/(−)α4 Agonist Binding Site in (α4)3(β2)2 Subtype Nicotinic Acetylcholine Receptors Permits Differential Agonist Desensitization Pharmacology versus the (α4)2(β2)3 Subtype

R. Lukas, J. Lindstrom, P. Whiteaker, 2014, The Journal of Pharmacology and Experimental Therapeutics.

Characterization of Nicotinic Acetylcholine Receptors Expressed by Cells of the SH-SY5Y Human Neuroblastoma Clonal Line

R. Lukas, L. Lucero, S. Norman, 1993, Molecular and Cellular Neuroscience.

Differential expression of nicotinic acetylcholine receptor subunits in fetal and neonatal mouse thymus

Y. Kuo, R. Lukas, D. Deluca, 2002, Journal of Neuroimmunology.

A Novel Nicotinic Acetylcholine Receptor Subtype in Basal Forebrain Cholinergic Neurons with High Sensitivity to Amyloid Peptides

R. Lukas, M. Sierks, Qiang Liu, 2009, The Journal of Neuroscience.

Electrophysiological, Pharmacological, and Molecular Evidence for α7-Nicotinic Acetylcholine Receptors in Rat Midbrain Dopamine Neurons

R. Lukas, Andrew A. George, S. Marxer-Miller, 2004, Journal of Pharmacology and Experimental Therapeutics.

Inducible, heterologous expression of human α7-nicotinic acetylcholine receptors in a native nicotinic receptor-null human clonal line

R. Lukas, S. Leonard, J. Fryer, 1999, Brain Research.

From 2-Triethylammonium Ethyl Ether of 4-Stilbenol (MG624) to Selective Small-Molecule Antagonists of Human α9α10 Nicotinic Receptor by Modifications at the Ammonium Ethyl Residue

M. Pallavicini, C. Gotti, P. Whiteaker, 2022, Journal of medicinal chemistry.

Subnanomolar Affinity and Selective Antagonism at α7 Nicotinic Receptor by Combined Modifications of 2-Triethylammonium Ethyl Ether of 4-Stilbenol (MG624)

M. Pallavicini, C. Gotti, F. Clementi, 2022, Journal of medicinal chemistry.

Neurotoxicity of channel mutations in heterologously expressed α7‐nicotinic acetylcholine receptors

J. Changeux, D. Bertrand, R. Lukas, 2001, The European journal of neuroscience.

Notice of retraction.

R. Lukas, T. Audhya, G. Goldstein, 1993, Molecular pharmacology.

Differential α4(+)/(−)β2 Agonist-binding Site Contributions to α4β2 Nicotinic Acetylcholine Receptor Function within and between Isoforms*

R. Lukas, J. Lindstrom, P. Whiteaker, 2015, The Journal of Biological Chemistry.

Structure-activity studies of 7-heteroaryl-3-azabicyclo[3.3.1]non-6-enes: a novel class of highly potent nicotinic receptor ligands.

R. Lukas, S. R. Breining, B. Bhatti, 2012, Journal of medicinal chemistry.

Analogs of α‐conotoxin PnIC selectively inhibit α7β2‐ over α7‐only subtype nicotinic acetylcholine receptors via a novel allosteric mechanism

Sean B. Christensen, P. Whiteaker, M. Watkins, 2023, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

The Unique α4(+)/(−)α4 Agonist Binding Site in (α4)3(β2)2 Subtype Nicotinic Acetylcholine Receptors Permits Differential Agonist Desensitization Pharmacology versus the (α4)2(β2)3 Subtype

P. Whiteaker, Yongchang Chang, L. Lucero, 2014, The Journal of Pharmacology and Experimental Therapeutics.